Director/PDMR Shareholding

RNS Number : 9166Y

Venn Life Sciences Holdings PLC

28 February 2013

 



Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that David Evans, Non Executive Chairman of the Company, has transferred 12,368 ordinary shares from his own name into his pension fund. The shares were transferred at a price of 31.5p

There has been no change in David Evans' beneficial shareholding in Venn as a result of these transactions.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer	Tel: [phone]
Paul Foulger, Finance Director	Tel: [phone]
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance)	Tel: [phone]
John Goold (Institutional Sales)	Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or Mob: [phone]
Paul McManus	[e-mail]

 

END

 

 

RDSLLFSFFRITFIV